Alcohol abuse changes behavior and can induce major mood disorders such as depression. Recent evidence in pre-clinical rodent models and humans now supports the conclusion that the innate immune system is an important physiological link between alcoholism and major depressive disorders. Deficiency of toll-like receptor 4 (TLR4), a protein that has been known to immunologists for 50 years, not only prevents lipopolysaccharide (LPS)-induced sickness behavior but recently has been demonstrated to induce resistance to chronic alcohol ingestion. Activation of the immune system by acute administration of LPS, a TLR4 agonist, as well as chronic infection with Bacille Calmette-Guérin (BCG), causes development of depressive-like behaviors in pre-clinical rodent models. Induction of an enzyme expressed primarily in macrophages and microglia, 2,3 indoleamine dioxygenase, shunts tryptophan catabolism to form kynurenine metabolites. This enzyme is both necessary and sufficient for expression of LPS and BCG-induced depressive-like behaviors in mice. New findings have extended these concepts to humans by showing that tryptophan catabolites of 2,3 indoleamine dioxygenase are elevated in the cerebrospinal fluid of hepatitis patients treated with the recombinant cytokine interferon-a. The remarkable conservation from mice to humans of the impact of inflammation on mood emphasizes the ever-expanding role for cross-talk among diverse physiological symptoms that are likely to be involved in the pathogenesis of alcohol abuse. These findings present new and challenging opportunities for scientists who are engaged in brain, behavior and immunity research.
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Alcohol abuse causes activation of immune to brain inflammatory signals
Alcohol intoxication is well known to affect the liver, but the brain is also a target. It is therefore not surprising that alcohol addiction shares a high rate of co-morbidity with numerous mood disorders (Kessler et al., 1994) , with symptoms of depression being the most common (Swendsen et al., 1998) . Even after years of research in humans and animals, using models of acute and chronic exposure to alcohol as well as withdrawal from alcohol, there is no real consensus as to whether alcoholism predisposes to development of depression or vice versa (reviewed in Spanagel (2009)). In reality, the line that connects alcoholism to depression probably has arrows that point both ways. During the past few years, a new player has emerged in the field of alcohol abuse and alcoholism. Surprisingly, that player is the immune system in the form of systemic and CNS inflammation (Irwin and Miller, 2007) . Among other biochemical changes, recent evidence has established that the brains of alcoholics display an increase in monocyte chemoattractant protein-1 (CCL2) and in well accepted region-specific microglial markers such as ionized calcium binding adaptor protein-1 (Iba-1) (He and Crews, 2008) . Systemic concentrations of cytokines are increased in alcoholic subjects (Achur et al., 2010; He and Crews, 2008; He et al., 2009) . Similarly, a very conventional marker of systemic inflammation, high sensitivity C-reactive protein (hs-CRP), is elevated in men who consume excessive amounts (>280 g/day) of alcohol (Alho et al., 2004; Liukkonen et al., 2006) . These same observations have been described in men, but not women, with clinical depression (Liukkonen et al., 2006) . As might be expected, subjects in this Liukkonen et al. study who were heavy drinkers accounted for a significant amount of variability between hs-CRP and clinical depression. Finally, alcohol abuse not only induces inflammation in the body and brain, but it also causes significant changes in immunity (Irwin and Miller, 2007) and increases susceptibility to a variety of infections, particularly those of pulmonary origin (Zhang et al., 2008) .
In many ways, these exciting discoveries about relationships between alcohol abuse, behavior and the immune system have followed a route that mirrors earlier developments in the field of brain, behavior and immunity. Initial findings in this area focused on the role of stress hormones on immune responses that affect
